Not available
Quote | Bayerische Motoren Werke AG (OTCMKTS:BAMXF)
Last: | $113.45 |
---|---|
Change Percent: | -0.05% |
Open: | $113.45 |
Close: | $113.45 |
High: | $113.45 |
Low: | $113.45 |
Volume: | 301 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Bayerische Motoren Werke AG (OTCMKTS:BAMXF)
2024-04-23 15:45:20 ET Summary Rolls-Royce Holdings plc is a wonderful business, but now trades at a high price. The company's businesses include established and profitable civil aerospace, defense, and power systems divisions, which fund investments in electric engines and modula...
2024-04-08 09:15:00 ET Summary Intense competition will likely continue to erode Tesla, Inc.'s market position and already mediocre margins. It does not have a core competency in battery production and it relies on third parties for this crucial component of an EV. Its chargin...
Message Board Posts | Bayerische Motoren Werke AG (OTCMKTS:BAMXF)
Subject | By | Source | When |
---|---|---|---|
BMW To Settle SEC Charges Of Reporting Inflated | OTC_Buyer | investorshub | 09/25/2020 1:41:16 PM |
Meh | NathanH | investorshub | 08/20/2015 3:53:19 PM |
Testing | NathanH | investorshub | 11/20/2014 6:50:45 AM |
Emylers: BAMXF Financials 07/16/2014 00:42:18 Bayerische Motoren Werke AG Period Ending Total Revenu | Emylers | investorshangout | 07/16/2014 5:42:16 AM |
Stock_Tracker: Latest Bayerische Motoren Werke Ag (BAMXF) Headlines What Is General Motors Thinking | Stock_Tracker | investorshangout | 03/09/2014 5:18:59 AM |
News, Short Squeeze, Breakout and More Instantly...
Bayerische Motoren Werke AG Company Name:
BAMXF Stock Symbol:
OTCMKTS Market:
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Weir Group plc ADR (WEGRY) is expected to report for Q4 2023 So-Young International Inc. (SY) is expected to report for quarter end 2023-12-31 Atara Biotherapeutics Inc. (ATRA) is expected to report $-0.61 for Q4 2023 Adyen NV ADR (ADYEY) is expected to report for Q4 2023 Five Bel...
SuRo Capital Corp. (SSSS) is expected to report for quarter end 2023-12-31 Enviva Inc. (EVA) is expected to report $-0.76 for Q4 2023 Jushi Holdings Inc. - Class B (Sub Voting) (JUSHF) is expected to report $-0.04 for Q4 2023 U Power Limited (UCAR) is expected to report for quarter en...